The Injury Season at Roland Garros, and What the Science Says About Recovery
The Injury Season at Roland Garros, and What the Science Says About Recovery
Roland Garros 2026 has unfolded in the shadow of absences. Some of the sport's most compelling players are watching from the sidelines, not by choice but by injury. Their recoveries raise a question worth asking carefully: what does the nutritional science around musculoskeletal repair actually tell us?
The 2026 clay season has been defined as much by who is absent as by who is competing. Carlos Alcaraz, the two-time defending champion, withdrew before the tournament began after a wrist injury sustained at Barcelona refused to resolve. Holger Rune, the Danish No. 1 and one of the most electric players on tour, has been absent from competitive tennis since October 2025, when he ruptured his left Achilles tendon in the Stockholm semifinals. Jack Draper also missed the draw. These are not minor niggles. They are among the most serious and structurally complex injuries a professional athlete can face.
What connects them, beyond clay courts and ranking points, is the biology of repair: the months-long process by which the body rebuilds collagen, manages post-surgical inflammation, and gradually restores load tolerance to damaged tissue. That process is one where nutritional strategy matters considerably more than most general practitioners acknowledge.
The Biology of Tendon and Soft Tissue Repair
Tendon injuries are among the slowest healing structures in the body. Unlike muscle, which has a dense vascular supply, tendon tissue is relatively avascular and metabolically sluggish. Following surgical repair, healing proceeds through overlapping phases: an acute inflammatory phase in the first days and weeks, a proliferative phase during which fibroblasts lay down new collagen, and a remodelling phase that can continue for years. Each phase is sensitive to the biochemical environment in which it occurs.
The acute inflammatory phase is not the enemy. Controlled inflammation is a necessary signal that recruits the cellular machinery of repair. What becomes problematic is when systemic inflammatory burden is already elevated, as it tends to be in athletes operating on congested schedules, or when the resolution of inflammation is impaired. This is where omega-3 fatty acids enter the picture in a manner that is mechanistically coherent, not merely associative.
EPA and DHA, the two active long-chain fatty acids in marine omega-3 supplements, are precursors to a class of molecules called specialised pro-resolving mediators (SPMs), including resolvins and protectins, that actively terminate inflammatory signalling. This is distinct from the blunt suppression exerted by NSAIDs, which can actually impair certain phases of healing. Omega-3 supplementation does not prevent inflammation; it helps ensure that inflammation resolves in a timely and organised manner.
"Our findings suggest that omega-3 supplementation combined with aerobic exercise after an Achilles tendon injury may be able to accelerate the process of Achilles tendon regeneration and healing." — American Journal of Sports Medicine, 2025
What the Research Specifically Shows on Achilles Healing
A 2025 study published in the American Journal of Sports Medicine examined the effect of omega-3 supplementation combined with aerobic exercise on Achilles tendon healing following surgical repair. The combined intervention group showed measurably superior markers of tendon regeneration compared to exercise alone or a control, with improved collagen fibre organisation and reduced levels of the inflammatory markers TNF-alpha and IL-1 beta. The researchers concluded that omega-3 supplementation alongside graduated rehabilitation may accelerate Achilles tendon recovery.
Separately, research into fish oil's anti-inflammatory and antioxidant properties in tendon tissue has confirmed that EPA and DHA inhibit the production of eicosanoids derived from arachidonic acid, the prostaglandins and leukotrienes that drive chronic inflammatory states. In the context of Achilles repair, where incomplete resolution of inflammation is associated with inferior collagen organisation and elevated re-rupture risk, this mechanism is directly relevant.
Post-surgical inflammation more broadly has also been examined. A systematic review of studies on omega-3 administration in surgical patients found consistent reductions in circulating CRP and interleukin-6 levels in those who received EPA and DHA supplementation relative to controls. Earlier supplementation initiation, ideally pre-operatively, was associated with stronger attenuation of the inflammatory response.
Holger Rune's Recovery: A Case Study in Methodical Rehabilitation
Rune's approach to his Achilles recovery has been notably disciplined for a 22-year-old athlete accustomed to competing at the highest level. He travelled to Aspetar in Doha, one of the world's leading orthopaedic and sports medicine institutions, where he worked with specialist physiotherapists and trainers focused on this class of injury. He documented his progress systematically and set phase-by-phase milestones rather than working to arbitrary return dates.
October 2025
Left Achilles rupture during Stockholm Open semifinals. Surgery performed within days. Rune confirms the procedure went well and early rehabilitation begins immediately.
November 2025
Five weeks post-surgery, rehabilitation progresses to phase two. Rune shares detailed updates on strength testing and walking milestones.
January 2026
Travels to Aspetar in Doha for specialist rehabilitation. Sets February as the target for walking without a limp and increasing load.
March 2026
Returns to hitting on clay courts at the Mouratoglou Academy in Monaco, approximately 20 weeks post-surgery. A significant milestone by any clinical standard.
May 2026
Withdraws from Roland Garros as his Achilles concern persists through the clay swing. The focus remains on long-term structural integrity over accelerated return.
Rune has spoken publicly about his ambition to return stronger and more mature. That framing is not simply athletic optimism. Achilles ruptures, when rehabilitated methodically, frequently result in patients reporting comparable or superior function to pre-injury levels. The window of recovery, if managed well, is also a window of tissue remodelling that can produce a structurally more resilient tendon than existed before. Nutritional support during that window is not incidental to this outcome. It is part of the process.
Norway Omega and Elite Recovery
Holger Rune is among the athletes who take our Omega-3 of Norway. We do not claim that any supplement is a treatment for injury, and we would not. What we do believe, and what the clinical literature supports, is that the quality and consistency of omega-3 intake has a measurable effect on the biochemical conditions under which the body repairs itself.
The distinction between a high-quality, high-potency omega-3 and a standard retail product is not a marketing abstraction. It is a question of EPA and DHA concentration, oxidation status, and bioavailability. An oxidised fish oil capsule does not deliver the specialised pro-resolving mediators the literature describes. A dilute product taken inconsistently does not sustain the fatty acid ratios at tissue level that the research requires. These are formulation problems with biological consequences.
Our Omega-3 of Norway is produced from wild-caught Norwegian arctic fish, processed to IFOS standards, and third-party tested for heavy metals, dioxins, PCBs, and oxidation markers. Every batch is certificated. Concentration is declared, not estimated. That is the standard the science demands if the clinical benefits are to translate from the literature to the athlete taking the capsule.
Norway Omega does not make medical claims. This article is intended for informational purposes only. Anyone managing an injury should work with a qualified medical professional and registered sports nutritionist.
